Maximus, Inc. (MMS) is a McLean, Virginia-based provider of business process services, clinical assessments, and technology solutions to federal, state, and international government agencies. The company operates through U.S. Federal Services, U.S. Services, and Outside the U.S. segments. On Friday, shares of MMS tumbled 5.78% to $65.22, down $4.00 from the prior session's close of $69.22, as a risk-off tone that began with Thursday's technology-led rout broadened into government-services and IT names.
The primary driver behind the selloff in MMS is not company-specific news but a broad de-risking across equity markets. On Thursday, the Nasdaq Composite fell 5.5% and the S&P 500 dropped 4.4% in their steepest single-day declines in more than a year, as investors rotated out of artificial-intelligence-related trades. The selling spread Friday even as major indices attempted to stabilize, leaving diversified technology and government-services names vulnerable to catch-up selling.
The market's anxiety stems largely from the outcome of the U.S. midterm elections, in which Democrats swept control of Congress. Investors are weighing the possibility of tighter regulation of AI infrastructure and data-center buildouts, which could slow a major source of technology spending. While Maximus is not a semiconductor or hyperscaler, its growing emphasis on AI-enabled bids and technology modernization for public-sector clients means the company is not fully insulated from the shifting sentiment around government technology investment.
As a contractor whose largest segment serves the U.S. federal government, MMS is also exposed to uncertainty around government spending priorities following the change in congressional control. The company has already demonstrated how quickly contract terms can reshape its earnings outlook: earlier this year it lowered fiscal 2026 adjusted EPS guidance to a range of $7.90 to $8.20 after a temporary pause in performance incentives on a major Veterans Affairs contract. That recent history leaves investors quick to reassess the stock whenever political or fiscal risk headlines surface.
Adding to the pressure, the October U.S. jobs report released Friday showed the economy added 165,000 jobs, well above the roughly 59,000 that economists had expected. The stronger-than-anticipated reading reinforced concerns that the Federal Reserve may keep interest rates higher for longer, or even hike again, weighing on equity valuations and rate-sensitive corners of the market.
The decline in MMS occurred against a backdrop of elevated market volatility. The Cboe Volatility Index surged more than 60% in the prior session to its highest level in months, reflecting broad de-risking rather than a single-stock catalyst. Notably, MMS had been relatively resilient during Thursday's sharp technology decline, finishing modestly higher, but it gave back that ground decisively on Friday as selling pressure rotated into names outside the immediate semiconductor and AI complex. The move pushed the stock well off its recent highs and underscored how quickly market-wide risk aversion can overwhelm company fundamentals.
Investors will be watching several catalysts in the weeks ahead. Maximus is expected to report fiscal fourth-quarter results around November 19–20, which will offer updated detail on its Veterans Affairs contract economics, margin trends across its U.S. Federal Services and U.S. Services segments, and any revisions to its full-year outlook. Broader market direction, the path of interest rates, and any clarity from Washington on technology and federal-spending policy will also influence how quickly the stock can stabilize. The key risk remains whether the de-risking in government-services and technology names extends further before fundamental support reasserts itself.
Tickeron offers hundreds of AI-powered trading bots that monitor thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a way to track systematic approaches during periods of heightened volatility. Explore the Trending AI Robots page to see which strategies are currently leading.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for MMS crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on MMS as a result. In 55 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for MMS just turned positive on October 06, 2026. Looking at past instances where MMS's MACD turned positive, the stock continued to rise in 23 of 44 cases over the following month. The odds of a continued upward trend are 52%.
MMS moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where MMS advanced for three days, in 154 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
The Aroon Indicator entered an Uptrend today. In 100 of 186 cases where MMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
MMS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. MMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.082) is normal, around the industry mean (6.055). P/E Ratio (10.150) is within average values for comparable stocks, (33.838). Projected Growth (PEG Ratio) (0.380) is also within normal values, averaging (1.946). Dividend Yield (0.019) settles around the average of (0.025) among similar stocks. P/S Ratio (0.604) is also within normal values, averaging (9.907).
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of business process services to government health and human services agencies
Industry OfficeEquipmentSupplies